Cargando…
Gefitinib targets ZAP-70-expressing chronic lymphocytic leukemia cells and inhibits B-cell receptor signaling
Chronic lymphocytic leukemia (CLL) can be divided into groups based on biomarkers of poor prognosis. The expression of the tyrosine kinase ZAP-70 (member of the Syk tyrosine kinase family) in CLL cells is associated with shorter overall survival in CLL patients. Currently, there is a lack of targete...
Autores principales: | Dielschneider, R F, Xiao, W, Yoon, J-Y, Noh, E, Banerji, V, Li, H, Marshall, A J, Johnston, J B, Gibson, S B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649506/ https://www.ncbi.nlm.nih.gov/pubmed/25275600 http://dx.doi.org/10.1038/cddis.2014.391 |
Ejemplares similares
-
Reconstitution of T cell receptor signaling in ZAP-70-deficient cells by retroviral transduction of the ZAP-70 gene
Publicado: (1996) -
Cytokine Contents in Chronic Lymphocytic Leukemia: Association with ZAP70 Expression
por: Işıksaçan, Nilgün, et al.
Publicado: (2016) -
Smudge cell percentage as a surrogate marker for ZAP-70 expression in patients with chronic lymphocytic leukemia
por: Al-Kahiry, Waiel, et al.
Publicado: (2018) -
High CD74 expression correlates with ZAP70 expression in B cell chronic lymphocytic leukemia patients
por: Butrym, Aleksandra, et al.
Publicado: (2013) -
Combined analysis of ZAP-70 and CD38 expression in sudanese patients with B-cell chronic lymphocytic leukemia
por: Basabaeen, Ameen Abdulaziz, et al.
Publicado: (2019)